2017
DOI: 10.1016/j.bmc.2016.12.012
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, X-ray molecular structure, biological evaluation and molecular docking studies of some N 4 -benzyl substituted 5-nitroisatin-3-thiosemicarbazones

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(3 citation statements)
references
References 31 publications
0
3
0
Order By: Relevance
“…In view of this and as an extension of our earlier studies [36][37][38][39][40][41][42][43][44][45][46][47] aiming to the synthesis of novel isatin derivatives with enhanced or diverse biological activities, we very recently reported the synthesis of a series of N 4 -benzyl substituted 5-nitroisatin-3-thiosemicarbazones (derivatives of thiourea, a substrate-like urease inhibitor) as highly effective urease inhibitors. 48 Interestingly, all these compounds demonstrated either induced or increased urease inhibitory activity in comparison to the respective N 4 -phenyl substituted derivatives tested in our earlier assays. 38,45 Furthermore, a number of other derivatives of thiourea are reported to show promising glycation inhibitory activity.…”
Section: Introductionmentioning
confidence: 65%
“…In view of this and as an extension of our earlier studies [36][37][38][39][40][41][42][43][44][45][46][47] aiming to the synthesis of novel isatin derivatives with enhanced or diverse biological activities, we very recently reported the synthesis of a series of N 4 -benzyl substituted 5-nitroisatin-3-thiosemicarbazones (derivatives of thiourea, a substrate-like urease inhibitor) as highly effective urease inhibitors. 48 Interestingly, all these compounds demonstrated either induced or increased urease inhibitory activity in comparison to the respective N 4 -phenyl substituted derivatives tested in our earlier assays. 38,45 Furthermore, a number of other derivatives of thiourea are reported to show promising glycation inhibitory activity.…”
Section: Introductionmentioning
confidence: 65%
“…Although in other research they evaluated several isatin-3-hydrazonothiazolines as urease inhibitors, despite some good results, substituents like 5-OCF 3 and 5-F over the isatin ring decreased the activity in various cases [33,34]. In a more recent research, Pervez et al reported several thiosemicarbazone-isatin derivatives with important activity as a urease inhibitors with lower IC 50 (0.87 to 11.23 μM) than thiourea (IC 50 � 22.3 μM) [35][36][37]. According to the abovementioned background about this kind of products, we have designed a series of isatin-pyrazole hybrids that could be effective as antimicrobials.…”
Section: Introductionmentioning
confidence: 99%
“…Thiosemicarbazones possess a remarkable pharmacological profile, and occupy a prominent position in pharmaceutical chemistry on account of their broad biological activity such as antiparasitic, [3][4][5] antibacterial, [6][7] antiviral [8][9] and anticancer. [10][11][12] Currently, the application of thiosemicarbazones in cancer therapy is being most extensively investigated. In 2007, de Oliveira et al [13] reported a series of thiosemicarbazone derivatives, as well as their in vitro antiproliferative activity against eight human tumor cell lines, and compound 1-1 (Figure 1) was the most promising against michigan cancer foundation-7 (MCF-7) cell (IC 50 =0.25 µmol•L -1 ).…”
Section: Introductionmentioning
confidence: 99%